Catalyst Wire Dossier Catalyst Wire Dossier

Somavaratan

somavaratan · Versartis Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Somavaratan, covering 2018-03-09 to 2023-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD) [Phase 2]

See pricing